Results 1 to 10 of about 13,203 (159)

Antineutrophil cytoplasmic antibody-associated vasculitis predominantly manifesting tubulointerstitial nephritis: A case report

open access: yesSAGE Open Medical Case Reports, 2023
The common histopathology of antineutrophil cytoplasmic antibody-associated vasculitis comprises pauci-immune crescentic glomerulonephritis with concomitant tubulointerstitial nephritis.
Ken Nishioka   +13 more
doaj   +2 more sources

Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis [PDF]

open access: yesFrontiers in Immunology
BackgroundAnti-CD20 therapy with rituximab serves as the cornerstone of both induction and maintenance treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Chen Ye   +26 more
doaj   +2 more sources

Infective endocarditis mimicking antineutrophil-cytoplasmic-antibody-associated vasculitis with glomerulonephritis: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Infective endocarditis occasionally presents with antineutrophil cytoplasmic antibody positivity, leading to diagnostic challenges and confusion, as it can be mislabeled antineutrophil-cytoplasmic-antibody-associated vasculitis. Distinguishing
Ahmad Matarneh   +8 more
doaj   +2 more sources

Antineutrophil cytoplasmic antibody in uveitis and scleritis [PDF]

open access: yesAustralian and New Zealand Journal of Ophthalmology, 1991
AbstractWe report a case where the detection of antineutrophil cytoplasmic antibody (ANCA) at the time of diagnosis of a case of sclero‐uveitis predicted the later development of systemic features and prompted an early and definitive diagnosis of systemic vasculitis.
Richard L Cooper
exaly   +3 more sources

Clinical features and outcomes of elderly patients with antineutrophil cytoplasmic antibody-positive vasculitis: a single-center retrospective study [PDF]

open access: yesKidney Research and Clinical Practice, 2022
Background We aimed to investigate the clinical characteristics and outcomes of patients aged ≥65 years with antineutrophil cytoplasmic autoantibody (ANCA)-positive ANCA-associated vasculitis (AAV) in Korea.
Hyo Jin Kim   +3 more
doaj   +1 more source

Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves’ disease: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Dysthyroid optic neuropathy is the most commonly suspected diagnosis of optic neuropathy in Graves’ patients; however, other causes need to be ruled out.
Miki Sato-Akushichi   +3 more
doaj   +1 more source

Antineutrophil cytoplasmic antibodies (ANCA)-positive patient with infective endocarditis and chronic hepatitis B virus: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2020
Background Antineutrophil cytoplasmic antibodies comprise a family of autoantibodies that are often used as biomarkers for certain forms of small-vessel vasculitis; however, chronic infections tend to induce the production of antineutrophil cytoplasmic ...
Qian Zhang, Baoxian Shi, Hongbing Zeng
doaj   +1 more source

Antineutrophil cytoplasmic antibody-associated vasculitis in presence of positive antiphospholipid antibody: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Antineutrophil cytoplasmic antibody-associated vasculitis is dominated by inflammatory occlusion of small vessels, causing tissue ischemia in various organs.
Maassoumeh Akhlaghi Kalahroodi   +4 more
doaj   +1 more source

Glomerulonephritis associated with systemic sclerosis: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Systemic sclerosis is a multiorgan autoimmune disease that can overlap with other rheumatologic disorders; however, co-occurrence with antineutrophil cytoplasmic antibody-associated vasculitis is rare.
Sepehr Nayebirad   +6 more
doaj   +1 more source

Antineutrophil cytoplasm antibodies and vasculitis [PDF]

open access: yesArchives of Disease in Childhood, 1997
Systemic vasculitis is a rare condition and diagnosis is often difficult. Any organ system can be affected and patients can present with an insidiously progressive illness, a remitting/relapsing pattern, or acute multisystem failure. The early institution of aggressive and potentially toxic immunosuppression may be necessary to minimise permanent organ
M C, Nash, M J, Dillon
openaire   +2 more sources

Home - About - Disclaimer - Privacy